Drug-Associated Rhabdomyolysis in the FDA Adverse Event Reporting System (FAERS): A Disproportionality Analysis

arXiv:2511.00093 · q-bio.OT · Submitted 2025-10-30 · Read on arXiv

q-bio.OT

Submitted: 2025-10-30

Updated: 2026-10-20

Terminology

FDA Adverse Event Reporting System — 2× in this paper

Related papers

Current validation practice undermines surgical AI development
Similarity Analysis of Blood Count Reference Intervals Across Continents Reveals No Reproducible Population or Geography-Linked Structure and Supports Personalised Values